Limited coverage drugs – rotigotine

Last updated on September 26, 2024
Generic name rotigotine
Strength 2 mg/24h, 4 mg/24h, 6 mg/24h, 8 mg/24h
Form transdermal patch
Special Authority criteria Approval period

For the treatment of advanced-stage Parkinson’s disease, when the patient is receiving treatment with levodopa and requires additional adjunctive therapy.

Indefinite

Practitioner exemptions

  • None

Special notes

  • PharmaCare does not provide coverage of rotigotine for restless leg syndrome.

Special Authority requests